| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ADMA and the role of the genes: Lessons from genetically modified animals and human gene polymorphisms
|
Maas, Renke
|
|
2009
|
60 |
6 |
p. 475-480
6 p.
|
article
|
| 2 |
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—An update on patient populations with a wide range of cardiovascular risk
|
Böger, Rainer H.
|
|
2009
|
60 |
6 |
p. 481-487
7 p.
|
article
|
| 3 |
Asymmetric dimethylarginine: Understanding the physiology, genetics, and clinical relevance of this novel biomarker
|
Böger, Rainer H.
|
|
2009
|
60 |
6 |
p. 447-
1 p.
|
article
|
| 4 |
Cellular ADMA: Regulation and action
|
Teerlink, Tom
|
|
2009
|
60 |
6 |
p. 448-460
13 p.
|
article
|
| 5 |
Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock
|
Nakamura, Tsukasa
|
|
2009
|
60 |
6 |
p. 515-518
4 p.
|
article
|
| 6 |
Correlates of arterial stiffness in an ageing population: Role of asymmetric dimethylarginine
|
Ngo, Doan T.M.
|
|
2009
|
60 |
6 |
p. 503-507
5 p.
|
article
|
| 7 |
Editorial Board
|
|
|
2009
|
60 |
6 |
p. i-
1 p.
|
article
|
| 8 |
Extensive characterization of the human DDAH1 transgenic mice
|
Schwedhelm, Edzard
|
|
2009
|
60 |
6 |
p. 494-502
9 p.
|
article
|
| 9 |
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner
|
Nakamura, Tsukasa
|
|
2009
|
60 |
6 |
p. 525-528
4 p.
|
article
|
| 10 |
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers
|
Kurz, K.
|
|
2009
|
60 |
6 |
p. 508-514
7 p.
|
article
|
| 11 |
Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension
|
Maas, Renke
|
|
2009
|
60 |
6 |
p. 488-493
6 p.
|
article
|
| 12 |
Role of the PRMT–DDAH–ADMA axis in the regulation of endothelial nitric oxide production
|
Pope, Arthur J.
|
|
2009
|
60 |
6 |
p. 461-465
5 p.
|
article
|
| 13 |
The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients
|
Richir, M.C.
|
|
2009
|
60 |
6 |
p. 519-524
6 p.
|
article
|
| 14 |
The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation
|
Nicholson, Thomas B.
|
|
2009
|
60 |
6 |
p. 466-474
9 p.
|
article
|
Journal description